MARKET

PLXP

PLXP

PLx Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.968
+0.008
+0.17%
Closed 16:00 10/18 EDT
OPEN
4.960
PREV CLOSE
4.960
HIGH
4.970
LOW
4.950
VOLUME
1.88K
TURNOVER
--
52 WEEK HIGH
7.41
52 WEEK LOW
1.000
MARKET CAP
44.93M
P/E (TTM)
-1.2871
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PLXP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PLXP News

  • Edited Transcript of PLXP earnings conference call or presentation 9-Aug-19 12:30pm GMT
  • Thomson Reuters StreetEvents.09/13 22:38
  • Is PLx Pharma (NASDAQ:PLXP) Using Debt In A Risky Way?
  • Simply Wall St..09/10 17:03
  • PLx Pharma Inc. Presents Moderated Abstract and Simultaneous Publication on the Pharmacokinetic and Pharmacodynamics (PK/PD) Properties of its Novel, Liquid Aspirin Formulation at the 2019 European Society of Cardiology Congress
  • GlobeNewswire.09/03 10:50
  • PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10
  • GlobeNewswire.08/28 21:30

More

Industry

Biotechnology & Medical Research
-1.17%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About PLXP

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
More

Webull offers PLx Pharma Inc (PLXP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.